Harnessing CD4 + T cell responses in HIV vaccine development

Nature Medicine

Volumn 19, Issue 2, 2013, Pages 143-149

  Streeck, Hendrik ^a   D'souza, M Patricia ^b   Littman, Dan R ^c   Crotty, Shane ^d,e,f  

^a HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^f Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; CHEMOKINE RECEPTOR CXCR5; ENVELOPE PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTERLEUKIN 22; NEUTRALIZING ANTIBODY;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BINDING AFFINITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; DISEASE COURSE; GERMINAL CENTER; HUMAN; IMMUNOGENICITY; IMMUNOREGULATION; INNATE IMMUNITY; LYMPHOCYTIC CHORIOMENINGITIS; MEMORY CELL; MUCOSAL IMMUNITY; MUTATION; MUTATION RATE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SOMATIC HYPERMUTATION; TH1 CELL; UPREGULATION; VAGINA EPITHELIUM;

AIDS VACCINES; ANTIBODIES, NEUTRALIZING; CD4-POSITIVE T-LYMPHOCYTES; HIV ANTIBODIES; HUMANS; RECEPTORS, CXCR5;

EID: 84873531162     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3054     Document Type: Review

References (99)

1. Rerks-Ngarm, S. et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med. 361, 2209-2220 (2009
2. Walker, L.M. et al. A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals. PLoS Pathog. 6, e1001028 (2010
3. Walker, L.M. et al. Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science 326, 285-289 (2009
4. Walker, L.M. et al. Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature 477, 466-470 (2011
5. Simek, M.D. et al. Human immunodeficiency virus type 1 elite neutralizers: Individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm. J. Virol. 83, 7337-7348 (2009
6. Scheid, J.F. et al. Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature 458, 636-640 (2009
7. Scheid, J.F. et al. Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science 333, 1633-1637 (2011
8. Wu, X. et al. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science 333, 1593-1602 (2011
9. Wu, X. et al. Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. Science 329, 856-861 (2010
10. Zhou, T. et al. Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01. Science 329, 811-817 (2010
11. Huang, J. et al. Broad and potent neutralization of HIV-1 by a gp41-specific human antibody. Nature 491, 406-412 (2012
12. Zhou, L., Chong, M.M.W. & Littman, D.R. Plasticity of CD4+ T cell lineage differentiation. Immunity 30, 646-655 (2009
13. O'Shea, J.J. & Paul, W.E. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 327, 1098-1102 (2010
14. Crotty, S. The 1-1-1 fallacy. Immunol. Rev. 247, 133-142 (2012
15. Doria-Rose, N.A. et al. Breadth of human immunodeficiency virus-specific neutralizing activity in sera: Clustering analysis and association with clinical variables. J. Virol. 84, 1631-1636 (2010
16. Sather, D.N. et al. Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection. J. Virol. 83, 757-769 (2009
17. Crotty, S. Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol. 29, 621-663 (2011
18. Yu, D. et al. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity 31, 457-468 (2009
19. Johnston, R.J. et al. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 325, 1006-1010 (2009
20. Nurieva, R.I. et al. Bcl6 mediates the development of T follicular helper cells. Science 325, 1001-1005 (2009
21. Victora, G.D. et al. Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter. Cell 143, 592-605 (2010
22. Kroenke, M.A. et al. Bcl6 and Maf cooperate to instruct human follicular helper CD4+ T cell differentiation. J. Immunol. 188, 3734-3744 (2012
23. Chtanova, T. et al. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-TH1/TH2 effector cells that provide help for B cells. J. Immunol. 173, 68-78 (2004 (Pubitemid 38797327)
24. Ma, C.S. et al. Early commitment of naïve human CD4+ T cells to the T follicular helper (TFH) cell lineage is induced by IL-12. Immunol. Cell Biol. 87, 590-600 (2009
25. Petrovas, C. et al. CD4+ T follicular helper cell dynamics during SIV infection. J. Clin. Invest. 122, 3281-3294 (2012
26. Hong, J.J., Amancha, P.K., Rogers, K., Ansari, A.A. & Villinger, F. Spatial alterations between CD4+ T follicular helper, B, and CD8+ T cells during simian immunodeficiency virus infection: T/B cell homeostasis, activation, and potential mechanism for viral escape. J. Immunol. 188, 3247-3256 (2012
27. Lindqvist, M. et al. Expansion of HIV-specific T follicular helper cells in chronic HIV infection. J. Clin. Invest. 10.1172/JCI64314 (2012
28. Pallikkuth, S. et al. Impaired peripheral blood T-follicular helper cell function in HIV-infected nonresponders to the 2009 H1N1/09 vaccine. Blood 120, 985-993 (2012
29. Morita, R. et al. Human blood CXCR5+CD4+ T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 34, 108-121 (2011
30. Suto, A. et al. Development and characterization of IL-21-producing CD4+ T cells. J. Exp. Med. 205, 1369-1379 (2008 (Pubitemid 351831493)
31. Eto, D. et al. IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4+ T cell (TFH) differentiation. PLoS ONE 6, e17739 (2011
32. Chevalier, N. et al. CXCR5 expressing human central memory CD4+ T cells and their relevance for humoral immune responses. J. Immunol. 186, 5556-5568 (2011
33. Bentebibel, S.E., Schmitt, N., Banchereau, J. & Ueno, H. Human tonsil B-cell lymphoma 6 (BCL6)-expressing CD4+ T-cell subset specialized for B-cell help outside germinal centers. Proc. Natl. Acad. Sci. USA 108, E488-E497 (2011
34. Ma, C.S. et al. Functional STAT3 deficiency compromises the generation of human T follicular helper cells. Blood 119, 3997-4008 (2012
35. Weber, J.P., Fuhrmann, F. & Hutloff, A. T-follicular helper cells survive as long-term memory cells. Eur. J. Immunol. 42, 1981-1988 (2012
36. Liu, X. et al. Bcl6 expression specifies the T follicular helper cell program in vivo. J. Exp. Med. 209, 1841-1852 (2012
37. Ma, C.S., Deenick, E.K., Batten, M. & Tangye, S.G. The origins, function, and regulation of T follicular helper cells. J. Exp. Med. 209, 1241-1253 (2012
38. Barr, T. & Gray, D. TFH memory: More or less TFH? Eur. J. Immunol. 42, 1977-1980 (2012
39. Lu, K.T. et al. Functional and epigenetic studies reveal multistep differentiation and plasticity of in vitro-generated and in vivo-derived follicular T helper cells. Immunity 35, 622-632 (2011
40. Lüthje, K. et al. The development and fate of follicular helper T cells defined by an IL-21 reporter mouse. Nat. Immunol. 13, 491-498 (2012
41. Simpson, N. et al. Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus. Arthritis Rheum. 62, 234-244 (2010
42. Craft, J.E. Follicular helper T cells in immunity and systemic autoimmunity. Nat. Rev. Rheumatol. 8, 337-347 (2012
43. Schaerli, P., Loetscher, P. & Moser, B. Cutting edge: Induction of follicular homing precedes effector TH cell development. J. Immunol. 167, 6082-6086 (2001 (Pubitemid 33081532)
44. Qi, H., Cannons, J.L., Klauschen, F., Schwartzberg, P.L. & Germain, R.N. SAP-controlled T-B cell interactions underlie germinal centre formation. Nature 455, 764-769 (2008
45. Kitano, M. et al. Bcl6 protein expression shapes pre-germinal center B cell dynamics and follicular helper T cell heterogeneity. Immunity 34, 961-972 (2011
46. Zhu, P. et al. Distribution and three-dimensional structure of AIDS virus envelope spikes. Nature 441, 847-852 (2006
47. Batista, F.D., Iber, D. & Neuberger, M.S. B cells acquire antigen from target cells after synapse formation. Nature 411, 489-494 (2001 (Pubitemid 32494396)
48. Lang, J. et al. B cells are exquisitely sensitive to central tolerance and receptor editing induced by ultralow affinity, membrane-bound antigen. J. Exp. Med. 184, 1685-1697 (1996 (Pubitemid 26404461)
49. Batista, F.D. & Harwood, N.E. The who, how and where of antigen presentation to B cells. Nat. Rev. Immunol. 9, 15-27 (2009
50. Thaunat, O. et al. Asymmetric segregation of polarized antigen on B cell division shapes presentation capacity. Science 335, 475-479 (2012
51. Batista, F.D. & Neuberger, M.S. B cells extract and present immobilized antigen: Implications for affinity discrimination. EMBO J. 19, 513-520 (2000 (Pubitemid 30093724)
52. Fleire, S.J. et al. B cell ligand discrimination through a spreading and contraction response. Science 312, 738-741 (2006
53. Mouquet, H. et al. Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation. Nature 467, 591-595 (2010
54. Burton, D.R. et al. A blueprint for HIV vaccine discovery. Cell Host Microbe 12, 396-407 (2012
55. Lai, L. et al. Prevention of infection by a granulocyte-macrophage colony-stimulating factor co-expressing DNA/modified vaccinia Ankara simian immunodeficiency virus vaccine. J. Infect. Dis. 204, 164-173 (2011
56. Barouch, D.H. et al. Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys. Nature 482, 89-93 (2012
57. Haynes, B.F. et al. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N. Engl. J. Med. 366, 1275-1286 (2012
58. Rolland, M. et al. Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2. Nature 490, 417-420 (2012
59. Montefiori, D.C. et al. Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials. J. Infect. Dis. 206, 431-441 (2012
60. Purtha, W.E., Tedder, T.F., Johnson, S., Bhattacharya, D. & Diamond, M.S. Memory B cells, but not long-lived plasma cells, possess antigen specificities for viral escape mutants. J. Exp. Med. 208, 2599-2606 (2011
61. Dosenovic, P. et al. BLyS-mediated modulation of naive B cell subsets impacts HIV Env-induced antibody responses. J. Immunol. 188, 6018-6026 (2012
62. Kasturi, S.P. et al. Programming the magnitude and persistence of antibody responses with innate immunity. Nature 470, 543-547 (2011
63. Alonso, M.J. et al. Determinants of release rate of tetanus vaccine from polyester microspheres. Pharm. Res. 10, 945-953 (1993 (Pubitemid 23211414)
64. Crotty, S. et al. Cutting edge: Long-term B cell memory in humans after smallpox vaccination. J. Immunol. 171, 4969-4973 (2003 (Pubitemid 37432774)
65. Crotty, S. & Ahmed, R. Immunological memory in humans. Semin. Immunol. 16, 197-203 (2004 (Pubitemid 38569900)
66. Amanna, I.J., Carlson, N.E. & Slifka, M.K. Duration of humoral immunity to common viral and vaccine antigens. N. Engl. J. Med. 357, 1903-1915 (2007 (Pubitemid 350074686)
67. Taub, D.D. et al. Immunity from smallpox vaccine persists for decades: A longitudinal study. Am. J. Med. 121, 1058-1064 (2008
68. Radbruch, A. et al. Competence and competition: The challenge of becoming a long-lived plasma cell. Nat. Rev. Immunol. 6, 741-750 (2006 (Pubitemid 44453460)
69. Amanna, I.J. & Slifka, M.K. Mechanisms that determine plasma cell lifespan and the duration of humoral immunity. Immunol. Rev. 236, 125-138 (2010
70. Good-Jacobson, K.L. & Shlomchik, M.J. Plasticity and heterogeneity in the generation of memory B cells and long-lived plasma cells: The influence of germinal center interactions and dynamics. J. Immunol. 185, 3117-3125 (2010
71. Soghoian, D.Z. et al. HIV-specific cytolytic CD4+ T cell responses during acute HIV infection predict disease outcome. Sci. Transl. Med. 4, 123ra25 (2012
72. Wilkinson, T.M. et al. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat. Med. 18, 274-280 (2012
73. Lieberman, J. Granzyme A activates another way to die. Immunol. Rev. 235, 93-104 (2010
74. Vojnov, L. et al. The majority of freshly sorted simian immunodeficiency virus (SIV)-specific CD8+ T cells cannot suppress viral replication in SIV-infected macrophages. J. Virol. 86, 4682-4687 (2012
75. de Souza, M.S. et al. The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope. J. Immunol. 188, 5166-5176 (2012
76. Kolls, J.K. & Khader, S.A. The role of TH17 cytokines in primary mucosal immunity. Cytokine Growth Factor Rev. 21, 443-448 (2010
77. Elsaesser, H., Sauer, K. & Brooks, D.G. IL-21 is required to control chronic viral infection. Science 324, 1569-1572 (2009
78. Yi, J.S., Du, M. & Zajac, A.J. A vital role for interleukin-21 in the control of a chronic viral infection. Science 324, 1572-1576 (2009
79. Haining, W.N. & Wherry, E.J. Integrating genomic signatures for immunologic discovery. Immunity 32, 152-161 (2010
80. Newell, E.W., Sigal, N., Bendall, S.C., Nolan, G.P. & Davis, M.M. Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8+ T cell phenotypes. Immunity 36, 142-152 (2012
81. Johnston, R.J., Choi, Y.S., Diamond, J.A., Yang, J.A. & Crotty, S. STAT5 is a potent negative regulator of TFH cell differentiation. J. Exp. Med. 209, 243-250 (2012
82. Ballesteros-Tato, A. et al. Interleukin-2 inhibits germinal center formation by limiting T follicular helper cell differentiation. Immunity 36, 847-856 (2012
83. Manel, N. et al. A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature 467, 214-217 (2010
84. Havenar-Daughton, C., Kolumam, G.A. & Murali-Krishna, K. Cutting Edge: The direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection. J. Immunol. 176, 3315-3319 (2006 (Pubitemid 43363977)
85. Li, Q. et al. Glycerol monolaurate prevents mucosal SIV transmission. Nature 458, 1034-1038 (2009
86. Harker, J.A., Lewis, G.M., Mack, L. & Zuniga, E.I. Late interleukin-6 escalates T follicular helper cell responses and controls a chronic viral infection. Science 334, 825-829 (2011
87. Douek, D.C. et al. HIV preferentially infects HIV-specific CD4+ T cells. Nature 417, 95-98 (2002 (Pubitemid 34498823)
88. Chomont, N. et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat. Med. 15, 893-900 (2009
89. Qureshi, H. et al. Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb Step trial of a similar HIV-1 vaccine. J. Virol. 86, 2239-2250 (2012
90. Buchbinder, S.P. et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): A double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372, 1881-1893 (2008
91. Mattapallil, J.J. et al. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434, 1093-1097 (2005 (Pubitemid 40663481)
92. Okoye, A. et al. Profound CD4+/CCR5+ T cell expansion is induced by CD8+ lymphocyte depletion but does not account for accelerated SIV pathogenesis. J. Exp. Med. 206, 1575-1588 (2009
93. Miller, C.J. et al. Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J. Virol. 79, 9217-9227 (2005 (Pubitemid 40934833)
94. Pandrea, I. et al. Paucity of CD4+CCR5+ T cells is a typical feature of natural SIV hosts. Blood 109, 1069-1076 (2007 (Pubitemid 46220653)
95. Paiardini, M. et al. Low levels of SIV infection in sooty mangabey central memory CD4+ T cells are associated with limited CCR5 expression. Nat. Med. 17, 830-836 (2011
96. Nakanishi, Y., Lu, B., Gerard, C. & Iwasaki, A. CD8+ T lymphocyte mobilization to virus-infected tissue requires CD4+ T-cell help. Nature 462, 510-513 (2009
97. Kumamoto, Y., Mattei, L.M., Sellers, S., Payne, G.W. & Iwasaki, A. CD4+ T cells support cytotoxic T lymphocyte priming by controlling lymph node input. Proc. Natl. Acad. Sci. USA 108, 8749-8754 (2011
98. Shin, H. & Iwasaki, A. A vaccine strategy that protects against genital herpes by establishing local memory T cells. Nature 10.1038/nature11522 (2012
99. Plotkin, S.A., Orenstein, W.A. & Offit, P.A. Vaccines (W.B. Saunders Company, 2008